230 related articles for article (PubMed ID: 28399096)
1. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
2. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
4. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
Vereşiu IA
Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
[TBL] [Abstract][Full Text] [Related]
5. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
6. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
7. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic polyneuropathy. Sequential therapy with alpha-lipoic acid passes the general practice test].
Hedding-Eckerich M; Eckert MW
MMW Fortschr Med; 2000 Sep; 142(36):38. PubMed ID: 11021068
[No Abstract] [Full Text] [Related]
10. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
11. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
Foster TS
Diabetes Educ; 2007; 33(1):111-7. PubMed ID: 17272797
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological significance of alpha lipoic acid in up to date treatment of diabetic neuropathy].
Becić F; Kapić E; Rakanović-Todić M
Med Arh; 2008; 62(1):45-8. PubMed ID: 18543755
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of thiolepta in diabetic polyneuropathy: results of the study ETIKA].
Strokov IA; Fokina AS; Golovacheva VA; Kochetov AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):36-41. PubMed ID: 23739501
[TBL] [Abstract][Full Text] [Related]
17. A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy.
Nguyen N; Takemoto JK
J Pharm Pharm Sci; 2018; 21(1s):177s-191s. PubMed ID: 30139425
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness and safety of alprostadil combined with alpha lipoic acid in the treatment of diabetic peripheral neuropathy: A protocol for systematic review and meta-analysis.
Guan H; Ye M; Fang C; Zhang L; Han P; Qiu S; Fang X; Li L
Medicine (Baltimore); 2020 Dec; 99(50):e23507. PubMed ID: 33327292
[TBL] [Abstract][Full Text] [Related]
19. Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis.
Prado MB; Adiao KJB
Can J Diabetes; 2024 Jun; 48(4):233-243.e10. PubMed ID: 38295879
[TBL] [Abstract][Full Text] [Related]
20. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
